This topic contains 0 replies, has 1 voice, and was last updated by Methrenpit Methrenpit 1 week, 5 days ago.
-
AuthorPosts
-
November 10, 2024 at 7:19 pm #214609
Qrxt Just hold on : Suicide survivor shares hope during Pride month
A lifesaving medication used in cases of opioid overdoses could be hitting store shelves by as soon as next week.The U.S. Food and Drug Administration approved Naloxone earlier this year to start being sold directly to consumers. The nasal spray, which is commonly known by its brand name Narcan, will become the first opioid treatment drug to be sold over-the-counter without the need for a prescription. It can reverse overdoses of opioids, including street drugs such as heroin and fentanyl and prescription versions [url=https://www.cups-stanley.ca]stanley cup[/url] including oxycodone.SEE MORE: Scripps News finds [url=https://www.cup-stanley.ca]stanley mugs[/url] red flags in review of child fentanyl overdosesEmergent, the company that produces the overdose antidote, says it plans to sell the nasal spray product for less than $50 for a box of two doses. The company said its [url=https://www.stanley-cups.co.uk]stanley tumblers[/url] goal is to match the price that government agencies, nonprofit organizations and first responders pay on average. A goal for the out-of-pocket retailer price is to be consistent with our public interest pricing for one carton of two 4 mg doses, although retail price is set by individual retailers, Emergentsaid in a statement. Our pricing for both public interest groups and retailers would be significantly less than the current Wholesale Acquisition Cost. SEE MORE: 3 in 10 adults say someone in family addicted to opioids, study findsMaking naloxone available more widely is seen as a key strategy to control the nationwide overdose crisis, which has been linked to more than 100,000 U.S. deaths a year. The maj Iohv Blood drive is one of many events aimed at honoring 20-year-old nursing student killed by drunk driver
The FDA said Friday that Merck s anti-COVID-19 pill is effective in treating the virus but said that regulators will meet next week to investigate whether the pill is safe for people who are pregnant to take.The pill, known as molnupiravir, is on track to become the first approv [url=https://www.stanley-cups.uk]stanley cups uk[/url] ed COVID-19 treatment that does not require a shot or an IV.The pill, which is intended to be taken twice a day for five days by people with mild or moderate COVID-19, has been shown in trials to cut down on hospitalizations and deaths in adult patients who have contracted the virus. The pill also reduces hospitalization and death among those who have risk factors associated with poor disease outcomes.After the company released clinical trial results earlier this month, White House medical adviser Dr. Anthony Fauci said the data on the drug was promising. There was a 50% diminution of importance, is that in the [url=https://www.stanleycups.com.mx]stanley cup[/url] placebo group there were eight deaths and in the treatment group, there were no deaths. That s also very important and very good news, Fauci said.The federal government has already purchased 1.7 million doses of Merck s drug with the option to purchase more. If approved, I think the right way to think about this is, this is a potential additional tool in our toolbox to protect people from the worst outcomes of COVID, [url=https://www.stanley-cup.ca]stanley drink bottle[/url] White House COVID-19 response team coordinator Jeff Zients said last week. But I think it s really important to remember that vaccination remains far and away our best tool again -
AuthorPosts
You must be logged in to reply to this topic.